Skip to content

Search

Leukaemia Translational Research

The main aim of our Leukaemia Translational Research Team is to test innovative therapeutic approaches, with a focus on clinical translation of this knowledge, to improve the outcomes of children suffering from leukaemia.

New study uncovers dual benefit of bone-protecting treatment for childhood leukaemia

A groundbreaking study from cancer researchers at The Kids Research Institute Australia has identified a promising new therapeutic strategy for children battling the most common childhood cancer – B-cell acute lymphoblastic leukaemia.

Researchers unlock key to slowing leukaemia progression in kids

When three-year-old Flo Parker injured her hip on a camping trip five years ago, her parents thought it would be nothing more than a common childhood injury.

The Kids researchers awarded Raine Medical Research Foundation funding

Congratulations to three The Kids Research Institute Australia researchers, who have been awarded funding from the Raine Medical Research Foundation.

Philanthropy powering our people at PitchFest!

For the third year running, ten emerging researchers took to the stage to pitch their innovative research projects at our annual Illuminate PitchFest event, inspiring a room full of donors of their vision and commitment to drive improved health outcomes for kids.

Suicidal behaviours: Prevalence estimates from the second Australian Child and Adolescent Survey of Mental Health and Wellbeing

Mental disorders should be a leading intervention point for suicide prevention both in the primary health sector and in the mental health sector specifically

CAGEd-oPOSSUM: motif enrichment analysis from CAGE-derived TSSs

CAGEd-oPOSSUM can identify transcription factors that act as key regulators of genes involved in specific mammalian cell and tissue types

The association between dog walking, physical activity and owner’s perceptions of safety: cross-sectional evidence from the US and Australia

This multi-site international study provides further support for the potential for dog walking to increase levels of daily physical activity

Safety and immunogenicity of a booster dose of a 3-antigen Staphylococcus aureus vaccine (SA3Ag) in healthy adults: A randomized phase 1 study

Immune responses after the initial vaccination persisted for the 12 months studied, with little additional response after the booster dose at 6 months